Published in Blood Weekly, May 13th, 2004
The recently completed study explored the growing theory suggesting that nicotine, given at low doses may be useful in treating heart failure. Endovasc is pleased to report that the outcome of these studies confirm and extend earlier studies supporting the case that nicotine can boost the regenerative abilities of stem cells in patients with heart failure.
Heart Watch is a quarterly newsletter published by the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.